← Every company
Agios Pharmaceuticals Inc SEC Filings
What Agios Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AGIO overview →Filings on file
137
since Nov 3, 2016
Warning signs
1
latest May 5, 2017
Last results
Jul 30, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 18, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jul 8, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 18, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 13, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 14, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 25, 2023 | Executive or director change 8-K | Read ↗ |
| Apr 19, 2023 | Executive or director change 8-K | Read ↗ |
| Dec 16, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 6, 2022 | Executive or director change 8-K | Read ↗ |
| Oct 7, 2022 | Executive or director change 8-K | Read ↗ |
| Sep 19, 2022 | Executive or director change 8-K | Read ↗ |
| Sep 7, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 15, 2022 | Executive or director change 8-K | Read ↗ |
| Jul 12, 2022 | Executive or director change 8-K | Read ↗ |
| May 26, 2022 | Executive or director change 8-K | Read ↗ |
| May 18, 2022 | Executive or director change 8-K | Read ↗ |
| Apr 26, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 4, 2021 | Executive or director change 8-K | Read ↗ |
| Jul 29, 2021 | Executive or director changeResults announced 8-K | Read ↗ |
| Jun 21, 2021 | Executive or director change 8-K | Read ↗ |
| Sep 8, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 5, 2019 | Executive or director change 8-K | Read ↗ |
| Feb 26, 2019 | Executive or director change 8-K | Read ↗ |
| Sep 5, 2018 | Executive or director change 8-K | Read ↗ |
| Dec 19, 2017 | Executive or director change 8-K | Read ↗ |
| Dec 5, 2017 | Executive or director change 8-K | Read ↗ |
| May 31, 2017 | Executive or director change 8-K | Read ↗ |
| Jan 4, 2017 | Executive or director change 8-K | Read ↗ |
| Nov 9, 2016 | Executive or director change 8-K | Read ↗ |
Source: Agios Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AGIO
Company overviewEverything on AGIO in one place, with the price.Insider tradingWhat AGIO's own officers and directors buy and sell.Who owns itEvery manager reporting a position in AGIO.Funds holding itWhich funds and ETFs hold AGIO, and how big a bet.LobbyingWhat AGIO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AGIO's account, and who they worked for.Federal contractsWhat federal agencies pay AGIO.PatentsWhat AGIO is filing at the patent office.